Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia
Clinical trial NCT00148590 · TERMINATED
Trial details
- NCT number
- NCT00148590
- Sponsor
- M. Schaefer, MD
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.